PharmaCyte Biotech, Inc.
PMCB • NASDAQ
PharmaCyte Biotech, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Joshua N. Silverman, with a market cap of $6.5M. As of Q3 2025, 6% of shares are held by 21 institutional investors, with GEODE CAPITAL MANAGEMENT LLC as the largest holder at 1.86%.
Interim Chief Executive OfficerJoshua N. Silverman
Market Cap$6.5M
Biotechnology
Healthcare
Employees2.0
Websitepharmacyte.com
Country
United States of America
Overview
Overview of institutional ownership in PMCB as of Q3 2025 with a market cap of $6.6M
All Institutions
- Institutions
- 21
- Value Held
- $419.9K
- Shares Held
- 433.0K
- Avg Position
- $20.0K
- Median Position
- $522.0
Hedge Funds
- Hedge Funds
- 3
- Value Held
- $117.1K
- Shares Held
- 120.7K
- Avg Position
- $39.0K
- Median Position
- $25.4K
Ownership Breakdown
Based on market cap of $6.6M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Biggest Investors
Institutions with the largest positions in PMCB as of Q3 2025
| Institution | Position Value |
|---|---|
 GEODE CAPITAL MANAGEMENT LLC ETF Provider | $122.8K 0.00% of portfolio |
E EQUITEC PROPRIETARY MARKETS, LLC Institution | $80.2K 0.48% of portfolio |
 RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | $77.6K 0.00% of portfolio |
 VANGUARD GROUP INC Institution | $72.7K 0.00% of portfolio |
 Schonfeld Strategic Advisors LLC Hedge Fund•Multi-Strategy | $25.4K 0.00% of portfolio |
 NORTHERN TRUST CORP Institution | $18.6K 0.00% of portfolio |
 CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $14.1K 0.00% of portfolio |
T Tower Research Capital LLC Institution | $5.4K 0.00% of portfolio |
 UBS Group AG Institution | $1.3K 0.00% of portfolio |
S SIMPLEX TRADING, LLC Institution | $1.0K 0.00% of portfolio |
Net Capital Flow
Institutional buying and selling activity for PMCB in Q3 2025
- Traded
- −$123.9K
- Buyers
- 9
- Sellers
- 9
- Total Bought
- +$48.3K
- Total Sold
- −$172.3K
- Avg Position
- $14.0K
Biggest Buyers
| Institution | Net Bought |
|---|---|
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | +$29.3K +30.2K shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | +$14.1K +14.5K shares |
T Tower Research Capital LLC Institution | +$2.7K +2.8K shares |
UBS Group AG Institution | +$1.3K +-21.3K shares |
S SIMPLEX TRADING, LLC Institution | +$1.0K +1.1K shares |
 MORGAN STANLEY RIA/Wealth | +$8.9 +8.0 shares |
 FINANCIAL CONSULATE, INC RIA/Wealth | +$2.0 +2.0 shares |
B BlackRock, Inc. Institution | +$1.0 +1.0 shares |
 CITIGROUP INC Institution | +$1.0 +1.0 shares |
Biggest Sellers
| Institution | Net Sold |
|---|---|
VANGUARD GROUP INC Institution | −$115.9K −119.5K shares |
 SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | −$30.4K −27.6K shares |
 DIMENSIONAL FUND ADVISORS LP Long Only Manager | −$22.3K −20.3K shares |
N NATIONAL BANK OF CANADA /FI/ Institution | −$3.6K −3.3K shares |
 RAYMOND JAMES FINANCIAL INC RIA/Wealth | −$48.0 −44.0 shares |
 Park Square Financial Group, LLC RIA/Wealth | −$40.0 −37.0 shares |
 BANK OF AMERICA CORP /DE/ Institution | −$3.9 −4.0 shares |
 Koesten, Hirschmann & Crabtree, INC. RIA/Wealth | −$2.0 −1.0 shares |
A Advisor Group Holdings, Inc. Institution | −$1.0 −1.0 shares |
Entry and Exit Activity
Institutions that initiated new positions or completely exited PMCB in Q3 2025
- New Positions
- 2
- New Value
- $3.0
- Exited Positions
- 6
- Exited Value
- $56.4K
New Positions
| Institution | Position Value |
|---|---|
FINANCIAL CONSULATE, INC RIA/Wealth | $2.0 2.0 shares |
CITIGROUP INC Institution | $1.0 1.0 shares |
Exited Positions
| Institution | Previous Position |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $30.4K 27.6K shares |
DIMENSIONAL FUND ADVISORS LP Long Only Manager | $22.3K 20.3K shares |
N NATIONAL BANK OF CANADA /FI/ Institution | $3.6K 3.3K shares |
RAYMOND JAMES FINANCIAL INC RIA/Wealth | $48.0 44.0 shares |
Park Square Financial Group, LLC RIA/Wealth | $40.0 37.0 shares |
Koesten, Hirschmann & Crabtree, INC. RIA/Wealth | $2.0 1.0 shares |
Options Activity
Institutions with the largest Call and Put options positions in PMCB as of Q3 2025
- Call Positions
- 1
- Call Value
- $10.3K
- Put Positions
- 0
- Put Value
- -
Call Positions
| Institution | Position Value |
|---|---|
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $10.3K 106.0 contracts |
Put Positions
| Institution | Position Value |
|---|---|
| No put positions found | |
Most Committed Institutions
Institutions with PMCB as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
E EQUITEC PROPRIETARY MARKETS, LLC Institution | 0.48% $80.2K |
Schonfeld Strategic Advisors LLC Hedge Fund•Multi-Strategy | 0.00% $25.4K |
T Tower Research Capital LLC Institution | 0.00% $5.4K |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | 0.00% $77.6K |
S SIMPLEX TRADING, LLC Institution | 0.00% $1.0K |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | 0.00% $14.1K |
GEODE CAPITAL MANAGEMENT LLC ETF Provider | 0.00% $122.8K |
 Sachetta, LLC RIA/Wealth | 0.00% $14.0 |
NORTHERN TRUST CORP Institution | 0.00% $18.6K |
VANGUARD GROUP INC Institution | 0.00% $72.7K |
Hedge Fund Spotlight
Discover hedge funds investing in PMCB
Schonfeld Strategic Advisors LLC
Hedge Fund • Multi-Strategy
Portfolio ManagerRyan Andrew Tolkin
- Portfolio Value
- $14.3B
- Positions
- 1,879
- Last Reported
- Q3 2025
Sector Allocation
Position in PharmaCyte Biotech, Inc.
- Market Value
- $25.4K
- Shares Held
- 26.2K
- Portfolio Weight
- 0.00%
- Owned Since
- 2021-Q3
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
ETF ETF | $1.3B | 9.09% | |
ETF ETF | $440.9M | 3.08% | |
Unknown Unknown | $337.6M | 2.36% |
